Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards
Holm H. Uhlig(University of Oxford), Aleixo M. Muise(University of Toronto), Kelsey Jones(Imperial College London), Judy H. Cho(Cedars-Sinai Medical Center), Marla C. Dubinsky(Icahn School of Medicine at Mount Sinai), Bernice Lo(Qatar Airways (Qatar)), Jochen Kammermeier(European CanCer Organisation), Hirokazu Kanegane(Tokyo Medical and Dental University), Sophie Hambleton(Newcastle upon Tyne Hospitals NHS Foundation Trust), Dermot McGovern(Salford Royal NHS Foundation Trust), Daniel Kotlarz(LMU Klinikum), Frank M. Ruemmele(Délégation Paris 5), Scott B. Snapper(Massachusetts General Hospital), Sibylle Koletzko(LMU Klinikum), Anne M. Griffiths(University of Toronto), Lissy de Ridder(Erasmus MC - Sophia Children’s Hospital), Bodo Grimbacher(University Medical Center Freiburg), Michael J. Lenardo(National Institutes of Health), David C. Wilson(University of Edinburgh), Simon Travis(University of Oxford), Ahmet Özen(Fakultet za Poslovni Menadžment u Baru), Dan Turner(Shaare Zedek Medical Center), Dror S. Shouval(Tel Aviv University), Ying Huang(Children's Hospital of Fudan University), Christoph Klein(Ludwig-Maximilians-Universität München), Claire Booth(Great Ormond Street Hospital)
Cited by 23
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
A guide to cancer immunotherapy: from T cell basic science to clinical practice
|Nature reviews. Immunology|2020|4.1k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k